Our Company

Meet the people, technology and culture working behind the scenes at Vivos® to promote better patient experiences and outcomes.

Board of Directors

R. Kirk Huntsman

CEO, Director

R. Kirk Huntsman is a founder of our company and has served as our Chief Executive Officer and a director since September 2016. In 1995 he founded Dental One (now Dental One Partners), which, as President and Chief Executive Officer he grew to become one of the leading DSOs (dental service organizations) in the country, with over 165 practices in 15 states. After a successful sale of Dental One to MSD Capital in 2008 and subsequent merger in 2009 with Dental Care Partners, Mr. Huntsman was appointed in 2010 as Chief Executive Officer of ReachOut Healthcare America, a Morgan Stanley Private Equity portfolio company. In 2012, he founded Xenith Practices, LLC, a DSO focused on rolling up larger independent general dental offices, which were sold in 2015. From January 2014 to September 2015, Mr. Huntsman founded and served as the Chief Executive Officer of Ortho Ventures, LLC, a US distributor of certain pediatric oral appliances with applications for pediatric sleep disordered breathing. Since November 2015, he has served as the Chief Executive Officer of First Vivos, Inc., which is now our wholly owned subsidiary. He was also a founding member of the Dental Group Practice Association (DGPA), now known as the Association of Dental Support Organizations (ADSO). He is the father of Todd Huntsman. He holds a BS degree in finance from Brigham Young University.

G. Dave Singh, DMD, Ph.D., DDSc. is a founder of our company and has served as our Chief Medical Officer and as a director since September 2016. Until June 2019, he also served as our President. Since January 2008, Dr. Singh has also served as the Chief Executive Officer of BioModeling Solutions, Inc., which became a wholly owned subsidiary. Dr. Singh is regarded as a leading professor in the field of SDB in all its many forms. His pioneering research into epigenetic influencers on craniofacial growth and development led to the development of the patented DNA appliance® and mRNA appliance® technology. He holds a DDSc in orthodontics from University of Dundee, UK, a Ph.D. in Craniofacial Development from University of Bristol, UK, and a BDS/DMD in dentistry from University of Newcastle, UK.

Dr. Dave Singh DMD PhD DDSc

Founder, Director and Chief Medical Officer

Ralph E. Green, DDS joined our board in June 2020. Since 2003, Dr. Green has served as President and Chief Executive Officer of his proprietary dental practice. Also since 2003, he has served as Vice President of Clinical Affairs for Reach Out Health Care America, a Morgan Stanley private equity company. From 2008 through 2009, Dr. Green served as President and CEO of LED Medial Diagnostics, a medical and dental manufacturer. From 1997 through 2002, he served as President and Chief Executive Officer of Zila Inc., a pharmaceutical company engaged in clinical trials and patent development. Dr. Green also previously served in various executive-level positions with multiple dental implant companies overseeing sales, developing new implant technology and business development. Prior to these positions, he served as an Assistant Professor at Tufts University Dental School in the 1970’s and 1980’s. Dr. Green is the President-Elect and a director of Dental Manufacturers of America.

Dr. Ralph Green, DDS

Director

Anja Krammer

Director

Anja Krammer joined our board in June 2020. In early 2020, Ms. Krammer was appointed as the Chief Executive Officer of Turn Biotechnologies, a development stage company focused on reversing aging and age-related diseases. From 2013 through 2018, she co-founded, served as President, Secretary and a director of BioPharmX, a specialty pharmaceutical company she led the initial public offering onto the New York Stock Exchange in 2015. Ms. Krammer served as Chief Marketing Officer/Founder of MBI, Inc., a management consulting firm beginning in January 1998. While at MBI, Inc., Ms. Krammer also served as Vice President Global Marketing from April 2006 to August 2008 for Reliant Technologies, a venture backed startup in aesthetic medicine. From April 2004 to April 2006, Ms. Krammer served as Sr. Director of Strategic Marketing for Medtronic Corporation. From December 2000 to September 2001, Ms. Krammer was Vice President, Solutions Marketing for Getronics Corporation, a global IT services company. From April 1999 to December 2000, Ms. Krammer served as Vice President, Indirect Channel Sales and Worldwide Industry Partnership Marketing in the Itronix Division of Acterna Corporation, an optical communications company. Ms. Krammer’s other prior roles include serving as Director of Worldwide Marketing and Communications for Tektronix Corporation in its Color Printing and Imaging Division from October 1997 to April 1999. From October 1995 to October 1997, Ms. Krammer was Director of Worldwide Sales and Marketing with KeyTronic Corporation, a computer equipment manufacturer. Ms. Krammer holds a BAIS degree with a focus on Marketing/Management from the University of South Carolina and an International Trade Certificate from the University of Paris—Sorbonne. We believe that Ms. Krammer should serve on our Board of Directors due to her experience in guiding healthcare and consumer enterprises in product development, sales and marketing management and commercialization strategies and her industry background in pharmaceuticals, medical devices, technology and consumer products.

Mark Lindsay

Director

Mark F. Lindsay joined our board in June 2020. He served on President Obama’s Transition Team and in President Clinton’s White House as Assistant to the President for the Office of Management and Administration. His areas of responsibility included the White House Military Office, which managed Air Force One; The White House Communications Agency; the Medical Unit and Camp David; running the White House Operations; and the Executive Office of the President’s Office of Administration, which was responsible for finance, information systems, human resources, legal/appropriations and security. Mr. Lindsay’s office was responsible for the logistics of all domestic and international Presidential travel and special air missions. President Clinton selected Mr. Lindsay to be the operational lead for the White House’s 2001 transition preparation and execution. Prior to his appointment to the White House, Mr. Lindsay served as senior legislative aid and counsel to Congressman Louis Stokes (D-OH). He worked closely with Democrats and the Congressional Black Caucus on a number of business and economic issues. He was also a member of Senator Hillary Clinton’s Minnesota Finance Committee for her 2008 Presidential campaign. Before joining The Livingston Group, Mr. Lindsay was with UnitedHealth Group, one of the world’s largest healthcare companies, where he held a number of senior positions including President of the AARP Pharmacy Services Division and Vice President of Public Communications and Strategy. Mr. Lindsay holds a graduate degree from Macalester College in St. Paul, Minnesota; a Juris Doctorate from Case Western Reserve University School of Law; a master’s degree in international Affairs from Georgetown University; and a graduate degree from the Advanced Management program at the University of Pennsylvania’s Wharton Business School. He is a member of the District of Columbia Bar.

Leonard Sokolow

Director

Leonard J. Sokolow joined our board in June 2020. Since 2015, Mr. Sokolow has been Chief Executive Officer and President of Newbridge Financial, Inc., a financial services holding company and Chairman of Newbridge Securities, Inc., its full service broker. From 2008 through 2012, he served as President of National Holdings Corporation, a publicly traded financial services company. From November 1999 until January 2008, Mr. Sokolow was Chief Executive Officer and President, and a member of the Board of Directors, of vFinance Inc., a publicly-traded financial services company, which he cofounded. Mr. Sokolow was the Chairman of the Board of Directors and Chief Executive Officer of vFinance Inc. from January 2007 until July 2008, when it merged into National Holdings Corporation, a publicly traded financial services company. Mr. Sokolow was Founder, Chairman and Chief Executive Officer of the Americas Growth Fund Inc., a closed-end 1940 Act management investment company, from 1994 to 1998. From 1988 until 1993, Mr. Sokolow was an Executive Vice President and the General Counsel of Applica Inc., a publicly-traded appliance marketing and distribution company. From 1982 until 1988, Mr. Sokolow practiced corporate, securities and tax law and was one of the founding attorneys and a partner of an international boutique law firm. From 1980 until 1982, he worked as a Certified Public Accountant for Ernst & Young and KPMG Peat Marwick. Since January 2016 Mr. Sokolow has served as a member of the Board of Directors of SQL Technologies Corp. (SQFL) and Chairman of its Audit Committee and since September 2016, Chairman of its Corporate Development Committee, and since November 2018, he has served as a Board Member and the Independent Manager of Masterworks.io, LLC and its affiliates. Mr. Sokolow was selected to serve as a member of our Board of Directors because of his experience as a director and principal executive officer, his legal, accounting, auditing and consulting background, and his qualifications to serve as our “audit committee financial expert.”

Matthew Thompson, M.D. joined our board in June 2020. Since December 2016, Dr. Thompson has served as Chief Medical Officer of Endologix, Inc., a publicly traded endovascular surgery technology firm. Prior to joining Endologix, Dr. Thompson served as Professor of Vascular Surgery at St. George's University of London and St George's Vascular Institute. Dr. Thompson's awards include a Hunterian Professorship, the Moynihan traveling fellowship and the gold medal for the intercollegiate examination. Dr. Thompson is also the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery. Dr. Thompson was Chair of the National Specialized Commissioning Clinical Reference Group for Vascular Services and is a founder of the British Society for Endovascular Therapy. Dr. Thompson is also a Council Member of the Vascular Society, Chairman of the Vascular Society Annual Scientific Meeting and was elected President of the Vascular Society for 2018. Dr. Thompson trained at Cambridge University, St. Bartholomew's Hospital, the University of Leicester and Adelaide.

Dr. Matt Thompson, MD FRCS

Director

Executive Management Team

R. Kirk Huntsman

Chief Executive Officer

Dr. Dave Singh DMD PhD DDSc

Founder, Director and Chief Medical Officer

Brad Amman

Chief Financial Officer

Susie McCullough

Sr. Vice President

Bryan Ferre

Chief Evangelist

RaeAnn Byrnes

Sr. Vice President

Todd Huntsman

Sr. Vice President

Edward Loew

Sr. Vice President

Cat Bonar

Chief Compliance Officer

Nick DeGenarro

SVP Medical Integration

Integrated Advisory Network

Vivos® is developing a global network of integrated advisors to support practitioners around the world.

 

 

Advisory Network

Integrated

Practice Advisor

Integrated

Clinical Advisor

Integrated

Market Advisor

Integrated

Practice Advisor

Vivos® Integrated Practice Advisors are practice management consultants and coaches  who provide guidance and specific services in support of successful integration.

Integrated

Clinical Advisor

Vivos® Integrated Clinical Advisors are practicing clinicians who have demonstrated leadership and a commitment to developing new clinicians. They provide clinical guidance and collaboration.

Integrated

Market Advisor

Vivos® Integrated Market Advisors provide consulting, coaching and specific market intelligence in support of practice growth and market distribution.

Articles + Research

The Vivos® Advisory Network provides full-time support for
Vivos® Integrated Practices.

 

 

Explore articles and research published by Vivos® and other clinical researchers.

 

 

Explore Articles + Research

Vivos® For Patients

At Vivos, we strive to provide useful information to help you when discussing your health concerns with your doctor. Our goal is to strengthen your relationship with your healthcare team to ensure proper diagnosis and treatment.

Call 866-908-4867

Vivos® For Healthcare Professionals

At Vivos, we support healthcare professionals around the world who are focused on treating the root cause of sleep disordered breathing including mild-to-moderate obstructive sleep apnea resulting from craniofacial deficiencies.

Vivos® For Investors

Our business is helping to address challenges throughout the world. We are helping to reduce the overall cost of healthcare by targeting a prevalent condition which contributes to many of the most expensive healthcare problems.

©2018-2020 Vivos® Therapeutics, Inc.  |  ALL RIGHTS RESERVED

All content found on the vivoslife.com website, including text, images, audio, or other formats were created for informational purposes only. The content of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. Individual results may vary. Nothing contained in this website infers or creates a warranty, promise, or guarantee of any kind with respect to the clinical outcome or result from treatment using the Vivos technology. The use of the Vivos technologies by any patient must always occur under the direction and supervision of a qualified, trained, and licensed dentist, physician or other qualified health provider, working in close collaboration with qualified medical personnel.